Beijing Tong Ren Tang Chinese Medicine Company Limited Stock
Stocks
3613
HK0000145638
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
23:31:23 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 5.680 HKD | +2.62% |
|
+1.97% | -32.86% |
| Market Cap | 4.63B 591M 529M 488M 442M 826M 56.23B 839M 5.82B 2.32B 29.43B 2.22B 2.17B 93.21B | P/E 2026 * |
10.2x | P/E 2027 * | 8.93x |
|---|---|---|---|---|---|
| Enterprise Value | 2.14B 273M 245M 226M 204M 382M 26.01B 388M 2.69B 1.07B 13.61B 1.03B 1B 43.12B | EV / Sales 2026 * |
1.45x | EV / Sales 2027 * | 1.78x |
| Free-Float |
28.32% | Yield 2026 * |
6.87% | Yield 2027 * | 7.86% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3613 | Delayed | |
Deutsche Boerse AG
| TQR | Delayed |
| 1 day | +2.62% | ||
| 1 week | +1.97% | ||
| Current month | +1.52% | ||
| 1 month | +1.52% | ||
| 3 months | -17.92% | ||
| 6 months | -22.62% | ||
| Current year | -32.86% |
| 1 week | 5.51 |  | 5.8 |
| 1 month | 5.4 | | 5.88 |
| Current year | 5.4 | | 9.38 |
| 1 year | 5.4 | | 9.5 |
| 3 years | 5.4 | | 13.44 |
| 5 years | 5.4 | | 16.66 |
| 10 years | 5.4 | | 17.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chi Wang
CEO | Chief Executive Officer | 51 | 2024-05-09 |
Fung Yi Tsang
DFI | Director of Finance/CFO | 50 | 2020-05-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Ngai Chi Chan
BRD | Director/Board Member | 54 | 2013-04-14 |
Yok Sing Tsang
BRD | Director/Board Member | 78 | 2017-09-11 |
Li Feng
BRD | Director/Board Member | 50 | 2022-08-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.62% | +1.97% | -33.57% | -52.67% | 598M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,148B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 652B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 505B | |
| +0.73% | +2.45% | +54.26% | +68.96% | 384B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 348B | |
| +2.38% | +2.65% | +34.31% | +57.95% | 294B | |
| +2.26% | +0.55% | +3.92% | +28.92% | 264B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 244B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 197B | |
| Average | +2.37% | +2.07% | +37.11% | +68.13% | 403.78B | |
| Weighted average by Cap. | +2.25% | +2.89% | +50.20% | +95.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.48B 189M 169M 156M 141M 264M 17.99B 268M 1.86B 743M 9.42B 709M 694M 29.82B | 1.66B 211M 189M 175M 158M 295M 20.12B 300M 2.08B 831M 10.53B 793M 776M 33.34B |
| Net income | 457M 58.22M 52.15M 48.11M 43.54M 81.41M 5.54B 82.73M 574M 229M 2.9B 219M 214M 9.19B | 518M 66.07M 59.18M 54.6M 49.41M 92.39M 6.29B 93.88M 651M 260M 3.29B 248M 243M 10.43B |
| Net Debt | -2.49B -317M -284M -262M -237M -444M -30.22B -451M -3.13B -1.25B -15.81B -1.19B -1.17B -50.09B | -1.68B -213M -191M -176M -160M -299M -20.33B -303M -2.1B -840M -10.64B -801M -784M -33.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | HK$5.680 | +2.62% | 392,000 |
| 26-10-29 | HK$5.535 | -1.25% | 604,000 |
| 26-10-28 | HK$5.605 | -1.58% | 702,000 |
| 26-10-27 | HK$5.695 | +1.15% | 649,000 |
| 26-10-26 | HK$5.630 | +1.08% | 800,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 3613 Stock
Select your edition
All financial news and data tailored to specific country editions
